Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)

Objectives: Cytomegalovirus (CMV) reactivation in patients with severe drug eruption on immunosuppressive therapy often leads to fulminant disease and even mortality, yet there are no biomarkers to accurately predict CMV reactivation either before or after immunosuppressive therapy. We aimed to asse...

Full description

Bibliographic Details
Main Authors: Y. Mizukawa, M. Kimishima, Y. Aoyama, T. Shiohara
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220307074
_version_ 1818943291366834176
author Y. Mizukawa
M. Kimishima
Y. Aoyama
T. Shiohara
author_facet Y. Mizukawa
M. Kimishima
Y. Aoyama
T. Shiohara
author_sort Y. Mizukawa
collection DOAJ
description Objectives: Cytomegalovirus (CMV) reactivation in patients with severe drug eruption on immunosuppressive therapy often leads to fulminant disease and even mortality, yet there are no biomarkers to accurately predict CMV reactivation either before or after immunosuppressive therapy. We aimed to assess whether patients who develop CMV reactivation (CMV-positive cases) have distinct immunological profiles from CMV-negative cases before and after immunosuppressive therapy. Methods: We performed serial cytokine/chemokine and regulatory T cells (Tregs) assessments of 45 patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS) during a follow-up period of nearly three years after onset. Results: Elevated IL-8, IL-10, IL-12p40, IL-15, TNF-α, G-CSF, and MIP-1α levels at baseline were associated with later development of CMV reactivation, while after starting treatment, IL-10 and IL-15 levels were associated with the onset of CMV reactivation; the use of corticosteroids obscured the large differences in these cytokines at baseline. CMV-positive cases were found to have normal Tregs frequencies at baseline, while negative cases had elevated frequencies. Higher eotaxin, IL-10, and G-CSF levels and lower IL-12p40 levels at baseline might be used for predicting the development of lethal CMV disease. Conclusions: The algorithm based on these results showed an accurate association with CMV reactivation.
first_indexed 2024-12-20T07:24:59Z
format Article
id doaj.art-ef099979bd504a8abd404562928a781d
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-12-20T07:24:59Z
publishDate 2020-11-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-ef099979bd504a8abd404562928a781d2022-12-21T19:48:35ZengElsevierInternational Journal of Infectious Diseases1201-97122020-11-01100239246Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)Y. Mizukawa0M. Kimishima1Y. Aoyama2T. Shiohara3Department of Dermatology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, Japan; Corresponding author at: Department of Dermatology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.Department of Dermatology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, JapanDepartment of Dermatology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, JapanDepartment of Dermatology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, JapanObjectives: Cytomegalovirus (CMV) reactivation in patients with severe drug eruption on immunosuppressive therapy often leads to fulminant disease and even mortality, yet there are no biomarkers to accurately predict CMV reactivation either before or after immunosuppressive therapy. We aimed to assess whether patients who develop CMV reactivation (CMV-positive cases) have distinct immunological profiles from CMV-negative cases before and after immunosuppressive therapy. Methods: We performed serial cytokine/chemokine and regulatory T cells (Tregs) assessments of 45 patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS) during a follow-up period of nearly three years after onset. Results: Elevated IL-8, IL-10, IL-12p40, IL-15, TNF-α, G-CSF, and MIP-1α levels at baseline were associated with later development of CMV reactivation, while after starting treatment, IL-10 and IL-15 levels were associated with the onset of CMV reactivation; the use of corticosteroids obscured the large differences in these cytokines at baseline. CMV-positive cases were found to have normal Tregs frequencies at baseline, while negative cases had elevated frequencies. Higher eotaxin, IL-10, and G-CSF levels and lower IL-12p40 levels at baseline might be used for predicting the development of lethal CMV disease. Conclusions: The algorithm based on these results showed an accurate association with CMV reactivation.http://www.sciencedirect.com/science/article/pii/S1201971220307074BiomarkersCytokine/chemokineCytomegalovirusDrug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)Immune reconstitution inflammatory syndrome (IRIS)
spellingShingle Y. Mizukawa
M. Kimishima
Y. Aoyama
T. Shiohara
Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)
International Journal of Infectious Diseases
Biomarkers
Cytokine/chemokine
Cytomegalovirus
Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)
Immune reconstitution inflammatory syndrome (IRIS)
title Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)
title_full Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)
title_fullStr Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)
title_full_unstemmed Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)
title_short Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)
title_sort predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy a single institution retrospective long term analysis of patients with drug induced hypersensitivity syndrome dihs drug reaction with eosinophilia and systemic syndrome dress
topic Biomarkers
Cytokine/chemokine
Cytomegalovirus
Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS)
Immune reconstitution inflammatory syndrome (IRIS)
url http://www.sciencedirect.com/science/article/pii/S1201971220307074
work_keys_str_mv AT ymizukawa predictivebiomarkersforcytomegalovirusreactivationbeforeandafterimmunosuppressivetherapyasingleinstitutionretrospectivelongtermanalysisofpatientswithdruginducedhypersensitivitysyndromedihsdrugreactionwitheosinophiliaandsystemicsyndromedress
AT mkimishima predictivebiomarkersforcytomegalovirusreactivationbeforeandafterimmunosuppressivetherapyasingleinstitutionretrospectivelongtermanalysisofpatientswithdruginducedhypersensitivitysyndromedihsdrugreactionwitheosinophiliaandsystemicsyndromedress
AT yaoyama predictivebiomarkersforcytomegalovirusreactivationbeforeandafterimmunosuppressivetherapyasingleinstitutionretrospectivelongtermanalysisofpatientswithdruginducedhypersensitivitysyndromedihsdrugreactionwitheosinophiliaandsystemicsyndromedress
AT tshiohara predictivebiomarkersforcytomegalovirusreactivationbeforeandafterimmunosuppressivetherapyasingleinstitutionretrospectivelongtermanalysisofpatientswithdruginducedhypersensitivitysyndromedihsdrugreactionwitheosinophiliaandsystemicsyndromedress